Pegzilarginase-nbln
Generic Name: pegzilarginase-nbln
Manufactured by IMMEDICA PHARMA AB. Dosage form: Injectable. Route: Injection. Active ingredients: PEGZILARGINASE-NBLN (0.1MG/KG). Application: BLA761211.
Overview
Manufactured by IMMEDICA PHARMA AB. Dosage form: Injectable. Route: Injection. Active ingredients: PEGZILARGINASE-NBLN (0.1MG/KG). Application: BLA761211.
Dosage
Available as injectable for injection use.
Related Medications
Amlodipine Maleate
amlodipine maleate
Manufactured by DR REDDYS LABS LTD. Dosage form: CAPSULE. Route: ORAL. Active ingredients: AMLODIPINE MALEATE (5MG); BENAZEPRIL HYDROCHLORIDE (10MG). Application: NDA021714.
Defibrotide Sodium
defibrotide sodium
11 DESCRIPTION Defibrotide sodium is an oligonucleotide mixture with profibrinolytic properties. The chemical name of defibrotide sodium is polydeoxyribonucleotide, sodium salt. Defibrotide sodium is a polydisperse mixture of predominantly single-stranded (ss) polydeoxyribonucleotide sodium salts derived from porcine intestinal tissue having a mean weighted molecular weight of 14-19 kDa, and a potency of 27-39 and 28-38 biological units per mg as determined by two separate assays measuring the r
Betazole Hydrochloride
betazole hydrochloride
Manufactured by LILLY. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: BETAZOLE HYDROCHLORIDE (50MG/ML). Application: NDA009344.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.